Prospective review of parameters improves plan consistency, saves time
Targeting pyrimidine synthesis inhibits GSC self-renewal and tumorigenesis
Study affirms XRT’s utility
Relapse more likely with faster PSA doubling time
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Dose-escalation trial shows local control with low toxicity, low leptomeningeal recurrence
Two-stage procedure capitalizes on liver's ability to regenerate
Newly discovered signaling loop is shown to be druggable
Goals include reduced morbidity, shorter hospital stays
Companion studies reveal efficacy indicators for PD-1/PD-L1 inhibition
A comprehensive approach to genitourinary syndrome of menopause
Advertisement
Advertisement